ALK Inhibition for the Treatment of Refractory Epithelioid Inflammatory Myofibroblastic Sarcoma

Access this Article

Author(s)

    • Fujiya Mikihiro
    • Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Japan
    • Kohgo Yutaka
    • Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Japan

Journal

  • Internal Medicine

    Internal Medicine 53(19), 2177-2178, 2014

    The Japanese Society of Internal Medicine

Codes

Page Top